Before commercializing a pharmaceutical formulation, companies need to understand whether its composition, components, manufacturing approach, dosage form or intended use could potentially fall within third-party patent rights. That question is rarely answered by looking at the molecule alone. A generic, a 505(b)(2) product, a reformulation, a fixed-dose combination or a novel delivery system can each be technically distinct from the originator product and still intersect with patent families covering excipient systems, release mechanisms, solid-state forms or manufacturing steps.
What Is an FTO Search for a Pharmaceutical Formulation?
An FTO search identifies potentially relevant third-party patent rights associated with a formulation and its intended commercialization. It starts from the product as it will actually be made and sold — every technical feature that a claim could read on — and works outward into patent families, claim sets, legal status and target jurisdictions. The output is a structured, risk-oriented view of the patent environment surrounding a commercial product, not a novelty assessment of an invention.
FTO Search vs Patentability Search
These two exercises answer different questions and are frequently conflated. A patentability search asks whether protection can be obtained; an FTO search asks whether a product can be commercialized without potentially infringing relevant third-party rights. A product may be patentable and still present FTO concerns — the two outcomes are entirely independent.
Patentability Search
- Can we obtain a patent?
- Novelty and inventive step
- Prior art — any disclosure, anywhere, any status
- Informs filing strategy
- Invention-focused
FTO Search
- Can we commercialize without potentially infringing relevant third-party rights?
- Potentially enforceable patent rights
- Claims, not disclosures
- Jurisdiction-specific
- Commercialization strategy — product and market focused
Why Searching Only the API Is Not Enough
The most common failure mode in pharmaceutical FTO work is treating the active ingredient as the whole product. Patent risk can exist at every technical layer of a formulation, and layers below the API are often where later-filed, longer-lived rights sit. A compound patent may have expired while formulation, polymorph, delivery and process families covering the same commercial product remain in force in some jurisdictions.
- 01API
- 02Salt / Polymorph
- 03Particle Characteristics
- 04Composition
- 05Excipient System
- 06Dosage Form
- 07Release Mechanism
- 08Manufacturing Process
- 09Therapeutic Use
Each layer must be described precisely before searching begins. A tablet is not simply a tablet: it is a defined composition, at defined loading levels, with a defined excipient system, produced by a defined process, releasing the API according to a defined profile, for a defined indication and route of administration. Every one of those specifics is a potential claim limitation — and also a potential design-around lever.
What Patent Claims Matter in Formulation FTO?
FTO is claim-focused, not document-focused. A patent that mentions a formulation in its description does not automatically establish coverage of a product. What matters is whether each limitation of an in-force claim, properly construed in the relevant jurisdiction, can be mapped to a feature of the actual product. Disclosure informs the reading of the claim; it does not extend it.
Patent Disclosure
Patent Claims
Actual Product Features
= High-quality, enforceable patent draft
The claim-mapping chain
- Product feature — as manufactured and marketed, not as idealised.
- Claim limitation — each element of the independent claim, read in context.
- Technical mapping — whether the feature corresponds to the limitation.
- Jurisdiction — the territory where the right exists and would be enforced.
- Patent status — pending, granted and in force, expired, lapsed, abandoned.
- Potential relevance — a reasoned, documented characterisation, not a score.
Key Patent Areas to Investigate
A formulation FTO search should be scoped across eight technical areas. Each generates distinct search strategies, distinct classification coverage and distinct claim structures.
| Area | What it typically covers |
|---|---|
| 01 — Composition claims | API, excipients, stabilizers, surfactants, buffers, binders, disintegrants, preservatives, solubilizers and carriers. |
| 02 — Concentration & ratio claims | Weight percentages, concentration ranges, API-to-excipient ratios, pH, particle size and loading levels. |
| 03 — Dosage-form claims | Tablets, capsules, oral solutions, suspensions, injectables, topical, transdermal, buccal, nasal, ophthalmic and inhalation formulations. |
| 04 — Modified-release & drug delivery | Sustained, controlled, extended, delayed and pulsatile release, enteric coating, matrix systems, reservoir systems, multiparticulates and osmotic delivery. |
| 05 — Solid-state & physical form | Polymorphs, salts, solvates, hydrates, co-crystals, amorphous forms and crystalline forms. |
| 06 — Manufacturing & process claims | Mixing, granulation, drying, milling, coating, encapsulation, sterilization, lyophilization, compression and particle engineering. |
| 07 — Combination formulations | API combinations, ratios, therapeutic indications, dosage forms and combination delivery technologies. |
| 08 — Method-of-use claims | Disease, patient population, dosing schedule, treatment duration, combination therapy, sequential administration and route of administration. |
Scope is set by the product and target markets; not every area is relevant to every project.
Discuss your formulation FTO
Share your formulation, development stage and target markets, and we will outline a search scope.
Discuss your formulation FTOHow a Pharmaceutical FTO Search Is Conducted
A defensible formulation FTO follows a structured, documented sequence. Each step narrows the field while preserving traceability from the product back to the specific claims examined.
- 011. Define the product
- 022. Build the search concept
- 033. Search multiple patent dimensions
- 044. Expand patent families
- 055. Analyze legal status
- 066. Analyze claims
- 077. Review prosecution history
- 088. Build a risk-oriented FTO landscape
What each step involves
- Define the product: API, salt/form, dosage form, strength, excipients, ratios, concentrations, release profile, manufacturing route, intended use and target markets.
- Build the search concept: API terminology, formulation terminology, dosage form, excipient combinations, release mechanism, manufacturing terminology and therapeutic use.
- Search multiple dimensions: keyword, classification, assignee, inventor, citation, patent family, chemical structure, claim text and related families.
- Expand patent families: priority filings, international applications, national-stage entries, continuations, divisionals, grants and related applications.
- Analyze legal status: pending, granted and in force, expired, abandoned, lapsed, cancelled or disclaimed — per jurisdiction.
- Analyze claims: product feature → claim limitation → technical mapping → jurisdiction → status → potential relevance.
- Review prosecution history: original and amended claims, office actions, applicant responses, examiner amendments, arguments and claim cancellations.
- Build the FTO landscape: a structured view of families, technical focus, relevant claim areas, jurisdictions, status and potential relevance.
An Illustrative FTO Landscape
The deliverable of the process is a structured landscape that a product team, regulatory group and IP counsel can all read from. The table below is illustrative only — it uses hypothetical entries to show the structure, not results from any client engagement.
| Patent Family | Technical Focus | Relevant Claim Area | Jurisdiction | Status | Potential Relevance |
|---|---|---|---|---|---|
| Family A | Matrix sustained-release tablet | Composition + release profile | US, EP | Granted / in force | Requires detailed claim mapping |
| Family B | Crystalline salt form | Solid-state form | US, IN | Granted; term status to verify | Depends on the form actually used |
| Family C | Wet-granulation process | Process claims | EP | Pending | Monitor claim scope during prosecution |
| Family D | Enteric coating system | Composition + coating | JP, CN | Expired (verify locally) | Likely low, subject to verification |
| Family E | Dosing regimen for indication | Method of use | US | Granted / in force | Depends on label and intended use |
Illustrative structure only. Risk classification should be based on the project's methodology and legal review.
Why Jurisdiction Matters
An FTO position is not the same in every market. Patent rights are territorial: a family may be granted and in force in the United States, abandoned in Europe, never nationalised in India, and pending with different claim scope in Japan or China. The same product can therefore carry materially different FTO conclusions across markets. This is why target markets must be defined at the very beginning of the project — they determine which families are searched, which legal status data is verified, and which claim sets are actually mapped.
- 01Product
- 02Target markets
- 03Relevant patent rights
- 04Jurisdictional status
- 05Claim analysis
- 06Commercialization risk
For companies developing in India and commercializing internationally, this territoriality cuts both ways. A formulation that is clear for the Indian market may face in-force rights in the United States or Europe, and a phased launch strategy can be designed around that difference — provided the analysis is done before manufacturing scale-up and regulatory filings lock in the formulation.
When Should a Company Conduct an FTO Search?
FTO can create greater value when introduced earlier, while formulation choices remain flexible. Once a formulation has been fixed for pivotal studies, transferred to commercial manufacturing and described in a regulatory filing, the cost of changing an excipient system or release mechanism rises sharply.
| Stage | Business value of FTO at this point |
|---|---|
| Early R&D | Shapes technology selection before resources are committed to a constrained approach. |
| Formulation development | Excipient systems, release mechanisms and processes can still be chosen with patent context in mind. |
| Product selection | Supports comparison of candidate formulations on commercial as well as technical criteria. |
| Pre-clinical / development | Informs design-around decisions while changes remain relatively inexpensive. |
| Pre-launch | Highest urgency: identifies potentially blocking rights in target markets before commercial commitment. |
| Market expansion | New territories mean new patent rights; the analysis must be repeated per jurisdiction. |
What Can FTO Analysis Reveal?
FTO output is not only a list of risks. Handled as intelligence rather than as a compliance checkbox, the same dataset supports design, licensing and portfolio decisions.
- Potential blocking rights — third-party rights requiring deeper review and legal input.
- Expired technology — rights that may no longer be in force, subject to jurisdiction-specific verification.
- Design-around opportunities — technical features that may potentially be modified.
- Licensing opportunities — rights that may warrant licensing discussions.
- Portfolio gaps — areas where additional proprietary protection may be valuable.
- Competitive activity — patent families and assignees associated with competing technologies.
- White-space opportunities — technical areas where competitors appear less heavily protected.
How Hashi IP Solutions Approaches Formulation FTO
Hashi IP Solutions approaches formulation FTO as an integrated technical and patent intelligence exercise designed to transform patent information into decision-support intelligence for pharmaceutical product development and commercialization.
- 01Product understanding
- 02Formulation feature extraction
- 03Patent search
- 04Patent family analysis
- 05Claim mapping
- 06Legal status review
- 07Jurisdictional analysis
- 08Potential risk identification
- 09Design-around / IP strategy insights
Planning to Commercialize a Pharmaceutical Formulation?
Identify potentially relevant third-party patent rights before commercialization. Hashi IP Solutions can support formulation-focused patent searching, patent family analysis, claim-focused analysis, FTO landscapes and related IP intelligence.
Request an FTO consultation
Tell us about your formulation, development stage and intended commercialization markets. A Hashi IP Solutions expert will review your requirements and contact you.
Explore Related IP Intelligence Services
Related Hashi services
- Freedom to Operate Search
Our dedicated FTO search and clearance intelligence service.
- Patent Search
Full-spectrum searching across composition, process and use.
- Prior Art Search
Validity and novelty-focused searching.
- Patent Analytics
Landscapes, white space and competitive patent activity.
Frequently asked questions
It is a search that identifies potentially relevant third-party patent rights associated with a specific formulation and its intended commercialization. It covers the API, salt and polymorphic form, particle characteristics, composition, excipient system, concentration ranges and ratios, dosage form, release mechanism, manufacturing process and intended therapeutic use, analysed against claims in the target jurisdictions.
